The expansion is a good signal for an industry that slowed down, both in Chicago and nationwide, as interest rates rose and ...

The company is hoping longer follow-up will deliver enough positive trial data on its CRISPR T-cell therapies for blood ...

In 2021, research led by Ryan Flynn, MD, Ph.D., and his mentor, Nobel laureate Carolyn Bertozzi, Ph.D., opened a new chapter ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

Bay Area biotech company Tempest Therapeutics was once valued at more than $1 billion, but now it's running out of gas. Last week, the cancer researcher revealed plans to lay off all but five of its ...

Mosaic Therapeutics has secured the latest pieces in its combination medicine strategy by licensing two clinical stage tumor ...

Gilead Sciences said a combination of its cancer drug Trodelvy and Merck’s Keytruda delayed the growth of tumors in women ...

Market turmoil may have frozen the traditional IPO pipeline, but German antibody biotech Veraxa is turning to the special ...

Immunai will generate a publicly accessible multi-omic dataset for a Parker Institute cohort of over 1,000 cancer patients.

Please enter your username and password below, if you are not yet a member of BioTechniques remember you can register for ...

As a stock-picking sector, investors can benefit from deep fundamental research on individual biotech companies ...

India launched its indigenously developed HPV test kits to screen for cervical cancer. Supported by the Department of ...